Neonatal Seizure Registry - Developmental Functional EValuation
- Conditions
- EpilepsyCerebral PalsyStrokeNeonatal SeizureIntracranial HemorrhagesHypoxic-Ischemic EncephalopathyIntellectual Disability
- Registration Number
- NCT04337697
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.
- Detailed Description
Neonatal seizures due to brain injury (acute symptomatic seizures) are associated with high risk of neurodevelopmental disability in infancy. Although prognosis in early childhood is a critical question for parents and providers, outcomes beyond infancy are largely unknown. Further, parents of infants with neonatal seizures are at risk for mental health disorders, which can undermine their ability to care for a child with medical complexity and may contribute to impaired child development.
The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants enrolled at one of nine sites across the USA. Participants will be evaluated using developmental questionnaires and in-person neurodevelopmental testing. Parent well-being will be assessed at each time point.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 280
- Enrolled in NSR-II
- Alive at the start of the NSR-DEV study period
- Parent(s) who are English or Spanish literate (with assistance of interpreter)
- Neonates who were found to have exclusion criteria after NSR-II enrollment
- Risk for adverse outcome independent of seizures and underlying brain injury (including but not limited to: inborn errors of metabolism, fetal infection, brain malformation)
- Transient cause for seizures (e.g., mild hypoglycemia, hyponatremia, hypocalcemia with normal neuroimaging)
- Neonatal-onset epilepsy syndromes
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Full scale IQ (FSIQ) score for each child on the Wechsler Preschool and Primary Scale of Intelligence, 4th Edition (WPPSI-IV) At age 5.5 years during in-person study visit The WPPSI-IV is an in-person assessment administered by a psychologist or psychometrician that will be used to measure neurocognitive ability. Full Scale IQ (FSIQ) will be generated for each participant from the following subtests: Verbal Comprehension Index (VCI), Visual Spatial Index (VSI), Fluid Reasoning Index (FRI), Working Memory Index (WMI), Processing Speed Index (PSI), Receptive Vocabulary and Picture Naming.
- Secondary Outcome Measures
Name Time Method Change in scores over time for each child on the Vineland Adaptive Behavior Scales, 3rd Edition At enrollment study visit and annual visits when the child is age 3, 4, 5.5, 7, and 8 The Vineland Adaptive Behavior Scales Parent Form measures adaptive behavior and intellectual and developmental function. Adaptive behavior is predictive of functional performance in school and is linked to both cognitive and executive function. Scores for each participant at each timepoint are generated based on parent reports in the following categories: Communication, Daily Living Skills, Socialization, Motor Skills, Adaptive Behavior Composite (ABC). We will look at the change in score over time for each participant during the study period after the Vineland-3 is administered at each timepoint.
Trial Locations
- Locations (9)
Stanford University
๐บ๐ธStanford, California, United States
Cincinnati Children's Hospital Medical Center
๐บ๐ธCincinnati, Ohio, United States
Children's Hospital of Philadelphia
๐บ๐ธPhiladelphia, Pennsylvania, United States
University of Michigan
๐บ๐ธAnn Arbor, Michigan, United States
Duke University
๐บ๐ธDurham, North Carolina, United States
Boston Children's Hospital
๐บ๐ธBoston, Massachusetts, United States
Children's National Medical Center
๐บ๐ธWashington, District of Columbia, United States
University of California, San Francisco
๐บ๐ธSan Francisco, California, United States
Massachusetts General Hospital
๐บ๐ธBoston, Massachusetts, United States